Lithuania – Pharmaceutical products – Vaistų ir kitų farmacijos produktų pirkimas
Opportunity Score
Confidence: 35%
Complexity: medium
—
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This is a DPS notice for the supply of pharmaceutical products to Lithuanian hospitals, published by CPO LT. The DPS is ongoing (started 2023-04-17, end 2028-04-17) with no specific deadline for tender submission. The notice covers 9 lots with various pharmaceutical CPV codes, but only one lot (LOT-0000) has a title and description; the remaining lots are identified only by CPV codes. No estimated value, award criteria, or detailed eligibility criteria are provided. The procedure is restricted and electronic submission is required, only in Lithuanian. Key risks include the lack of explicit deadline and incomplete lot information.
Strengths
Documents available
Medium complexity
Electronic submission
Risks
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Electronic submission required.
- Submissions must be in Lithuanian.
- Restricted procedure: only invited candidates can submit tenders after a qualification stage.
Buyer
Name
Viešoji įstaiga CPO LT
Location
Vilnius, LTU
Website
Buyer profile
Identifier
302913276
Lots (3)
Main lot covering pharmaceutical and related products according to hospital needs.
Lot for pharmaceutical products categorized under CPV 33620000.
Lot for pharmaceutical products categorized under CPV 33630000.
Procurement Details
Publication
28 Nov 2024
Deadline
—
Procedure
restricted
Contract
supplies
Language
LIT
Publication #
730659-2024
Classification
Performance: Lithuania
Documents (2)
Opportunity Score
Confidence: 35%
Complexity: medium
—
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation